Dr. Steven Verveniotis is a Rockville Centre, New York based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 24 Maple Ave, Suite 6, Rockville Centre. Patients can reach him at 516-766-0580.
Dr. Steven Verveniotis deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Steven Verveniotis speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Steven Verveniotis
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
24 Maple Ave, Suite 6, Rockville Centre, New York, 11570
Phone:
516-766-0580
Fax:
516-766-6755
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
6002112919
Enrollment ID:
I20160302001513
NPI Number:
1730109786
NPI Enumeration Date:
20 Jul, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
24 Maple Ave, Suite 6 Rockville Centre, New York
Zip:
11570
Phone Number:
516-766-0580
Fax Number:
516-766-6755
Patients can reach Dr. Steven Verveniotis at 24 Maple Ave, Suite 6, Rockville Centre, New York or can call to book an appointment on 516-766-0580. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.